Search clinical trials for: Fingolimod Hydrochloride
Total 7323 results
-
Isfahan University of Medical SciencesShiraz University of Medical SciencesCompleted
-
University Hospital, Basel, SwitzerlandNovartisCompletedRett's SyndromeSwitzerland
-
NovartisCompletedEfficacy and Safety of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis (FREEDOMS)Relapsing-remitting Multiple SclerosisCanada, Australia, Israel, Belgium, Czech Republic, Finland, France, Germany, Greece, Lithuania, Netherlands, Poland, Russian Federation, Slovakia, South Africa, Sweden, Switzerland, Turkey, United Kingdom
-
Novartis PharmaceuticalsWithdrawnMultiple Sclerosis (Relapsing Remitting)
-
NovartisCompletedMultiple SclerosisGreece, Russian Federation, Switzerland, Germany, Israel, Ireland, Belgium, Finland, United Kingdom, Netherlands, Canada, Romania, Hungary, Poland, Czech Republic, Australia, Estonia, France, Slovakia, South Africa, Sweden, Turkey
-
University Hospital, CaenRecruitingMultiple SclerosisFrance
-
Novartis PharmaceuticalsTerminatedRelapsing-remitting Multiple Sclerosis (RRMS)United States, Canada, Mexico, Brazil, Puerto Rico, Argentina, Chile
-
Hoffmann-La RochePPDRecruitingRelapsing-Remitting Multiple SclerosisUnited States, Belgium, Canada, Spain, India, Italy, Mexico, Portugal, Austria, Brazil, United Kingdom, Germany, Netherlands, Serbia, Argentina, Australia, Bulgaria, France, Greece, Hungary, Poland, Ukraine, Estonia, Denmark, Croatia, Latvia and more
-
Asofarma S.A.I. y C.Zenith Technology Corporation LimitedCompletedHealthy VolunteersNew Zealand
-
Novartis PharmaceuticalsCompletedRelapsing-remitting Multiple SclerosisGermany
-
Novartis PharmaceuticalsCompletedMultiple SclerosisColombia, Panama, Peru, Brazil, Jordan, Malaysia, Mexico, Argentina
-
NovartisCompletedRenal InsufficiencyRussian Federation
-
Novartis PharmaceuticalsCompletedRelapsing-remitting Multiple SclerosisGermany
-
Heinrich-Heine University, DuesseldorfNovartis PharmaceuticalsTerminatedRelapsing Remitting Multiple SclerosisGermany
-
Novartis PharmaceuticalsCompletedMultiple Sclerosis | Relapsing-RemittingTurkey
-
Tianjin Medical University General HospitalCompletedStroke | Stroke, Acute | Cerebral Stroke | Ischemic Cerebrovascular Accident | Vascular AccidentChina
-
Novartis PharmaceuticalsTerminatedRelapsing Remitting Multiple Sclerosis (RRMS)Germany, Spain, Australia, Israel, Switzerland, Italy, Austria, Greece, Hungary, Czech Republic, Finland
-
Novartis PharmaceuticalsCompletedMultiple SclerosisItaly, Belgium, Germany
-
Tang-Du HospitalNot yet recruitingIntracerebral Hemorrhage
-
Novartis PharmaceuticalsRecruitingMultiple SclerosisDenmark, Spain, Switzerland, United States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Colombia, Cyprus, Czechia, Finland, France, Germany, Greece, Hungary, Ireland, Israel, Italy, Lebanon, Mexico, Netherlands, Norway, Poland, ... and more
-
Novartis PharmaceuticalsCompleted
-
Ning Wang, MD., PhD.Recruiting
-
Novartis PharmaceuticalsRecruiting
-
Novartis PharmaceuticalsCompletedRelapsing Forms of Multiple SclerosisGermany, South Africa, Italy, United States, Austria, Belgium, Czechia, Egypt, Hungary, Malaysia, Turkey, Spain, Australia, Canada, France, Israel, Netherlands, Switzerland, Greece, Korea, Republic of, Romania, Russian Federation, United... and more
-
Novartis PharmaceuticalsCompletedRelapsing Remitting Multiple Sclerosis RRMSGermany, Switzerland
-
Novartis PharmaceuticalsCompletedMultiple Sclerosis, Relapsing-RemittingFrance
-
NovartisCompletedMultiple SclerosisUnited States, Canada
-
Sidney Kimmel Comprehensive Cancer Center at Johns...CompletedGlioblastoma | Anaplastic AstrocytomaUnited States
-
Second Affiliated Hospital, School of Medicine,...Shaoxing People's Hospital; Huizhou Municipal Central Hospital; Taizhou Hospital and other collaboratorsWithdrawnStroke | InflammationChina
-
First Affiliated Hospital of Fujian Medical UniversityWithdrawn
-
Novartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsTerminated
-
Massachusetts General HospitalALS Therapy Development InstituteCompleted
-
Novartis PharmaceuticalsCompletedMultiple SclerosisUnited States, Australia, Canada, Mexico, Argentina, Puerto Rico, Chile
-
Novartis PharmaceuticalsCompletedRelapsing Multiple SclerosisUnited States
-
Hikma Pharmaceuticals LLCActive, not recruitingRelapsing-Remitting Multiple SclerosisEgypt
-
The Affiliated Hospital of Xuzhou Medical UniversityUnknown
-
McGill UniversityNovartisCompletedMultiple Sclerosis-Relapsing-RemittingCanada
-
NovartisMitsubishi Tanabe Pharma CorporationCompleted
-
General Hospital of Shenyang Military RegionRecruiting
-
Second Affiliated Hospital, School of Medicine,...Shaoxing People's Hospital; Huizhou Municipal Central Hospital; Taizhou Hospital and other collaboratorsRecruitingStroke | InflammationChina
-
Novartis PharmaceuticalsMitsubishi Tanabe Pharma CorporationCompletedChronic Inflammatory Demyelinating PolyradiculoneuropathySpain, United States, Belgium, Germany, Italy, Israel, Australia, France, United Kingdom, Netherlands, Czechia, Japan, Canada, Greece, Poland
-
NovartisCompletedMultiple SclerosisUnited States, Turkey, Romania, United Kingdom, Poland, Austria, Canada, Australia
-
Novartis PharmaceuticalsTerminatedAcute Demylelinating Optic NeuritisUnited States, Spain
-
Fondazione I.R.C.C.S. Istituto Neurologico Carlo...Patient-Centered Outcomes Research Institute; Universita degli Studi di GenovaTerminatedRelapsing Remitting Multiple SclerosisItaly
-
Novartis PharmaceuticalsWithdrawn
-
The Methodist Hospital Research InstituteEnrolling by invitationKidney Failure, Chronic | Kidney Transplant Rejection | Graft Rejection | Kidney Transplant; Complications | Kidney Transplant Failure | Kidney Transplant Failure and Rejection | Interstitial FibrosisUnited States
-
BiogenTerminatedRelapsing-Remitting Multiple SclerosisUnited States, Spain, Germany, Australia, Sweden, Czechia, France, Italy, United Kingdom
-
Mitsubishi Tanabe Pharma CorporationCompletedRelapsing-remitting Multiple SclerosisUnited Kingdom